DSD-T207
Congenital adrenal hyperplasia (CAH) · DSD-T207
Classic simple virilizing 21-hydroxylase deficiency (CAH) with pelvic inflammatory disease, adrenal myelolipoma, and a primary mesenteric tumor.
Case fields and evidence
- Category
-
Congenital adrenal hyperplasia (CAH)
- Age
-
58 years
- Sex
-
Male (socially male; ambiguous genitalia at birth, partial genital resection at age 3 years)
- Genetics
-
CYP17A1
- Diagnosis
-
Classic simple virilizing 21-hydroxylase deficiency (CAH) with pelvic inflammatory disease, adrenal myelolipoma, and a primary mesenteric tumor.
- Follow-up
-
Safely discharged after infection control; surgery to be scheduled electively.
- General phenotype
-
Male phenotype, short stature; CT showed a 10 cm left adrenal myelolipoma and a 3.2 cm hypervascular mass in the small bowel mesentery.
- Imaging
-
CT showed fluid in the vaginal cavity and Müllerian structures, a dilated and thickened left fallopian tube (salpingitis), a 10 cm left adrenal myelolipoma, and a 3.2 cm hypervascular mass in the small bowel mesentery; PET-CT showed high metabolism in the mesenteric mass (SUV 11.8) and heterogeneous uptake in the adrenal mass (SUV 5.5).
- Laboratory findings
-
17-OHP 13800 ng/dL (48800→50100 ng/dL after ACTH stimulation), ACTH 181 pg/mL, cortisol 8.6 μg/dL (9.2 after stimulation); renin 0.83 ng/mL/h, aldosterone 156.77 pg/mL; LH 0.1, FSH 0.5 mIU/mL, testosterone 6.75 ng/mL; WBC 15,100/mL, CRP 12.77 mg/dL.
- Management
-
Third-generation cephalosporin + metronidazole for infection for 2 weeks, with CRP decreasing to 0.12 mg/dL; planned excision of female internal genitalia and mesenteric and adrenal tumors, with perioperative stress-dose glucocorticoids.
- Pathology
-
Not reported in the source text.
- Evidence level
-
See source
- Clinical history
-
See source
- Family history
-
See source
- Growth and development
-
See source
Cite this resource
DSD Research Library | Congenital adrenal hyperplasia (CAH) · DSD-T207 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T207?version=v1.4.0